tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

Activists and 5% owners

Schedule 13D filings from the last 90 days. A 13D is required within 10 days of crossing 5% of a company by anyone who does not hold it passively. Item 4 says what the owner intends: board seats, a sale, a buyback, or nothing in particular. Quoted as filed.

295 filings.

Oct 26, 2026 13D PRIMECAP Odyssey Funds 6.6% of the shares new stake, above 5%
Mordecai Alfred Winborne · 50K shares · event Oct 22, 2026
Item 4, purpose of the transaction: The purpose of the transaction is for investment purposes only and not for the purpose of changing of influencing control of PRIMECAP Odyssey Discovery ETF ("POMG"). The Reporting Person may seek to acquire additional Shares of POMG and/or may dispose of some or all of their Shares, from time to time, by selling such Shares on the secondary market or otherwise, depending on price, market liquidity, developments affecting POMG.
Read the filing ↗
Oct 26, 2026 13D CPSH CPS Technologies Corp. 6.5% of CPSH's shares new stake, above 5%
Global Value Investment Corporation and 5 more reporting persons · 1.25M shares · event Oct 19, 2026
Item 4, purpose of the transaction: The Reporting Persons purchased the shares of Common Stock for investment purposes, and such purchases have been made in the ordinary course of business of the Reporting Persons. In pursuing such investment purposes, the Reporting Persons may further purchase, hold, vote, trade, dispose, or otherwise deal in the Common Stock at times, and in such manner, as they deem advisable to benefit from, among other things, (1) changes in the market prices of the shares of Common Stock; (2) changes in the Issuer's operations, business strategy, or prospects; or (3) from the sale or merger of the Issuer. To evaluate such alternatives, the Reporting Persons will closely monitor the Issuer's operations, …
Read the filing ↗
Oct 26, 2026 13D HEPA Hepion Pharmaceuticals, Inc. 19.9% of HEPA's shares new stake, above 5%
Gravitas Collective Corp. · 25.00M shares · event Oct 6, 2026
Item 4, purpose of the transaction: The Common Stock owned by the Reporting Person was acquired for investment purposes. The Reporting Person may make further acquisitions of the Common Stock from time to time. Except for the foregoing, the Reporting Person has no plans or proposals which relate to, or could result in, any of the matters referred to in Item 4 of Schedule 13D.
Read the filing ↗
Oct 26, 2026 13D City Therapeutics, Inc. 25.6% of the shares new stake, above 5%
ARCH Venture Fund XII, L.P. and 6 more reporting persons · 13.69M shares · event Oct 19, 2026
Item 4, purpose of the transaction: AVF XII and the other Reporting Persons acquired the Common Stock for investment purposes. Depending on market conditions, the continuing evaluation of the business and prospects of the Issuer and other factors, AVF XII and other Reporting Persons may dispose of or acquire additional shares of Common Stock of the Issuer. Except as set forth above, none of the Reporting Persons has any present plans which relate to or would result in the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D.
Read the filing ↗
Oct 26, 2026 13D AZUL Azul S.A. 7.9% of AZUL's shares new stake, above 5%
American Airlines Group Inc. and 1 more reporting person · 31.84M shares · event Oct 20, 2026
Item 4, purpose of the transaction: Warrant Exercise Item 3 above includes a description of the Warrant Exercise and is incorporated by reference to this Item 4. General The Reporting Persons acquired the securities described in this Schedule 13D in connection with the Warrant Exercise and intend to review their investment in the Issuer on a continuing basis. Any actions the Reporting Persons might undertake may be made at any time and from time to time without prior notice and will be dependent upon the Reporting Persons' review of numerous factors, including, but not limited to: an ongoing evaluation of the Issuer's business, financial condition, operations and prospects; price levels of the Issuer's securities; general m…
Read the filing ↗
Oct 26, 2026 13D ALDS APPlife Digital Solutions Inc 57.4% of ALDS's shares new stake, above 5%
Mammoth Crest Capital LLC and 4 more reporting persons · 8.21M shares · event Jun 13, 2025
Item 4, purpose of the transaction: The Reporting Persons acquired the securities in connection with the Reverse Merger, as compensation, and in connection with loans and credit support provided to the Issuer. Mr. Hill and Mr. Evans are executive officers and two of the Issuer's three directors and, together with MCC, may be deemed to control the Issuer. In those capacities they participate in the Issuer's management and in decisions of its Board of Directors. Increase in authorized Common Stock. The Issuer's authorized Common Stock is 20,000,000 shares, and outstanding and reserved shares exceed that number. On October 16, 2026, the Issuer's Board of Directors approved an amendment to the Issuer's Articles of Incorporation i…
Read the filing ↗
Oct 23, 2026 13D RADB Bradbury Capital Inc. 7.2% of RADB's shares new stake, above 5%
Ong Mei Yoong · 2.00M shares · event Oct 6, 2026
Item 4, purpose of the transaction: The acquisition by Ong Mei Yoong of the Shares (as hereinafter defined) as described herein was effected because of the belief that the Shares represent an attractive investment. Depending on prevailing market, economic and other conditions, Ong Mei Yoong may from time to time acquire additional Shares or engage in discussions with the Company concerning future acquisitions of shares of its capital stock. Such acquisitions may be made by means of open-market purchases, privately negotiated transactions, direct acquisitions from the Company or otherwise. Ong Mei Yoong intends to review his investment in the Company on a continuing basis and, depending upon the price and availability of shares…
Read the filing ↗
Oct 23, 2026 13D ABEO Abeona Therapeutics Inc. 6.1% of ABEO's shares new stake, above 5%
James Russell Revocable Trust and 1 more reporting person · 3.48M shares · event Oct 15, 2026
Item 4, purpose of the transaction: The Reporting Persons originally acquired the Shares for investment purposes and reported their beneficial ownership on Schedule 13G. Over time, based on their review of the Issuer's public filings, press releases and other public communications, the Reporting Persons became concerned regarding the Issuer's operational execution, the consistency of management's public statements with subsequent operating results, and the Issuer's governance. Beginning in May 2026, the Reporting Persons communicated their concerns (as a shareholder in an informal manner), to the Issuer's management and board of directors (the "Board"). On October 14, 2026, Mr. Russell met electronically with two members of…
Read the filing ↗
Oct 23, 2026 13D Oxford Park Income Fund, Inc. 24.8% of the shares new stake, above 5%
Oxford Gate Management, LLC and 3 more reporting persons · 521K shares · event Apr 3, 2023
Item 4, purpose of the transaction: Oxford Funds acquired the Shares in connection with its seed capital investment in connection with the launch of the Issuer. Oxford Gate acquired the Shares for investment purposes. Except as described in this Schedule 13D or in the Issuer's periodic and current reports filed with the SEC from time to time, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D, although the Reporting Persons, at any time and from time to time, may review, reconsider and change their position and/or change their purpose and/or develop such plans and may seek to influence manag…
Read the filing ↗
Oct 22, 2026 13D RADB Bradbury Capital Inc. 10.4% of RADB's shares new stake, above 5%
Yong Teck Hong · 2.90M shares · event Oct 6, 2026
Item 4, purpose of the transaction: The acquisition by Yong Teck Hong of the Shares (as hereinafter defined) as described herein was effected because of the belief that the Shares represent an attractive investment. Depending on prevailing market, economic and other conditions, Yong Teck Hong may from time to time acquire additional Shares or engage in discussions with the Company concerning future acquisitions of shares of its capital stock. Such acquisitions may be made by means of open-market purchases, privately negotiated transactions, direct acquisitions from the Company or otherwise. Yong Teck Hong intends to review his investment in the Company on a continuing basis and, depending upon the price and availability of sha…
Read the filing ↗
Oct 22, 2026 13D AACG ATA Creativity Global 34.5% of AACG's shares new stake, above 5%
Everrise Holdings LLC and 2 more reporting persons · 45.31M shares · event Jul 21, 2026
Item 4, purpose of the transaction: The Reporting Persons intend to participate in and influence the strategic direction, management and operations of the Issuer. The Reporting Persons may, from time to time, engage in discussions with the Issuer's board of directors, management and other shareholders regarding the Issuer's business, operations, management, financial condition, strategic plans, corporate governance, capital structure and other matters relating to the Issuer. The Reporting Persons may also introduce or provide business opportunities, industry relationships, strategic resources and other resources that may contribute to the development and growth of the Issuer's business and enhance shareholders' value. The Rep…
Read the filing ↗
Oct 22, 2026 13D MAT Mattel Inc /de/ 17.7% of MAT's shares new stake, above 5%
EdgePoint Investment Group Inc. · 50.52M shares · event Oct 21, 2026
Item 4, purpose of the transaction: The Reporting Person and the EdgePoint Funds acquired the shares of Common Stock to which this Schedule 13D relates for investment purposes in the ordinary course of business. The Reporting Person and the EdgePoint Funds acquired the shares of Common Stock because they believed that the shares of Common Stock reported herein, when purchased, represented an attractive investment opportunity. Subject to the terms and conditions of the Cooperation Agreement (as defined below), the Reporting Person intends to review its investment in the Issuer on a continuous basis to maximize the value of the Reporting Person's shares of the Common Stock. Depending on various factors including, without limi…
Read the filing ↗
Oct 21, 2026 13D POLA Polar Power, Inc. 10.0% of POLA's shares new stake, above 5%
Chris Mayer and 1 more reporting person · 478K shares · event Oct 6, 2026
Item 4, purpose of the transaction: The Reporting Persons acquired the securities described herein for investment purposes. On October 6, 2026, the Board of Directors of the Issuer (the "Board") appointed Mr. Mayer as Co-Chief Executive Officer of the Issuer, effective immediately. In that capacity, Mr. Mayer is responsible for the Issuer's corporate strategy and growth, consolidated financial performance, budgeting and profitability, fundraising, investor relations and capital markets, capital allocation and strategic investments, and Board communication. Pursuant to the Purchase Agreement, CL Investment has the right to designate one person for appointment or election to the Board, and designated Lewis Wilks, who serves as a…
Read the filing ↗
Oct 21, 2026 13D Frazier Life Sciences Acquisition Corp. II 20.5% of the shares new stake, above 5%
Frazier Life Sciences Holdings II LLC and 4 more reporting persons · 1.98M shares · event Oct 15, 2026
Item 4, purpose of the transaction: The information set forth in Items 3 and 6 hereof is incorporated by reference in its entirety into this Item 4. The securities described herein were acquired solely for investment purposes. The Reporting Persons reserve the right to acquire, or dispose of, additional securities of the Issuer in the ordinary course of their business, to the extent deemed advisable in light of their general investment and trading policies, market conditions or other factors. The Reporting Persons may engage in discussions from time to time with other stockholders of the Issuer regarding the acquisition by the Reporting Persons or others of shares of the Issuer's Ordinary Shares held by such stockholders. Add…
Read the filing ↗
Oct 21, 2026 13D ICON Icon Energy Corp. 9.0% of ICON's shares new stake, above 5%
Hampton Financial Corp. and 1 more reporting person · 325K shares · event Sep 28, 2026
Item 4, purpose of the transaction: Hampton acquired 325,000 Common Shares in the belief that such securities were an attractive investment. On September 28, 2026, Hampton sent a letter to the issuer's Chief Financial Officer, a copy of which is attached hereto as Exhibit 99.2 and is incorporated herein by reference. Except as set forth in this Schedule 13D (including in the aforementioned letter), the Reporting Persons currently do not have any plans or proposals that relate to or would result in any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. The Reporting Persons reserve the right to acquire, or cause to be acquired, additional securities of the Issuer, to dispose of, or cause …
Read the filing ↗
Oct 21, 2026 13D BGX Blackstone Long-Short Credit Income Fund 5.9% of BGX's shares new stake, above 5%
Saba Capital Management, L.P. known activist and 2 more reporting persons · 746K shares · event Oct 19, 2026
Item 4, purpose of the transaction: The Reporting Persons acquired the Common Shares to which this Schedule 13D relates in the ordinary course of business for investment purposes because they believe that the Common Shares are undervalued and represent an attractive investment opportunity. The Reporting Persons may engage in discussions with management, the Board of Trustees (the "Board"), other shareholders of the Issuer and other relevant parties, including representatives of any of the foregoing, concerning the Reporting Persons' investment in the Common Shares and the Issuer, including, without limitation, matters concerning the Issuer's business, operations, board appointments, governance, performance, management, capital…
Read the filing ↗
Oct 21, 2026 13D Ionic Digital Inc. 10.0% of the shares new stake, above 5%
Sachem Head Capital Management LP known activist and 3 more reporting persons · 4.50M shares · event Oct 20, 2026
Item 4, purpose of the transaction: The Reporting Persons purchased the shares of Series A Preferred Stock and Class A Common Stock because they believe they represent an attractive investment opportunity. The Reporting Persons intend to engage in discussions with the Issuer's management and board of directors (the "Board"), other stockholders of the Issuer and other interested parties on issues that may relate to the business, management, operations, assets, capitalization, financial condition, strategic plans, governance and Board composition and the future of the Issuer. The Reporting Persons may also take one or more of the actions described in clauses (a) through (j) of Item 4 of Schedule 13D and may discuss such actions …
Read the filing ↗
Oct 20, 2026 13D STWI Teg Overseas 31.1% of STWI's shares new stake, above 5%
Irodakhon Abduvakhitova · 58.59M shares · event Oct 13, 2026
Item 4, purpose of the transaction: On October 6, 2026, the Reporting Person, entered into a Share Exchange Agreement with the Issuer, Tourism and Entertainment Group LLC, a limited liability company organized under the laws of the Republic of Uzbekistan and in which Mr. Artikkhodjaev holds over 99% ownership interest ("TEG LLC" and together with the Reporting Person, the "Sellers"), TEG SPV, LLC, a limited liability company organized under the laws of the Republic of Uzbekistan ("TEG SPV"). Pursuant to the agreement, the Issuer agreed to acquire 99.99999012% of the membership interests in TEG SPV from the Sellers in exchange for an aggregate of 183,098,434 shares of the Issuer common stock (the "Exchange Shares"), 124,506,935…
Read the filing ↗
Oct 19, 2026 13D SKK Rantizo 9.0% of SKK's shares new stake, above 5%
Oldridge Phillip · 6.17M shares · event Oct 9, 2026
Item 4, purpose of the transaction: The Reporting Person acquired the securities reported herein pursuant to the Transaction as described in Item 3 above. The Reporting Person intends to work with the board of directors of the Issuer (the "Board"), members of management and/or other shareholders or other relevant parties with respect to operational, strategic, financial or governance matters or otherwise work with management and the Board with a view to maximizing shareholder value with respect to the Issuer and / or the Reporting Person. Without limiting the foregoing, the Reporting Person supports plans being considered by the Issuer to redomicile the Issuer to the United States and, in connection therewith or otherwise, may…
Read the filing ↗
Oct 16, 2026 13D TRex Bio, Inc. 7.0% of the shares new stake, above 5%
SV Biotech Crossover Opportunities Fund LP and 1 more reporting person · 1.92M shares · event Oct 8, 2026
Item 4, purpose of the transaction: The Reporting Persons initially acquired the Preferred Stock underlying the Shares for investment purposes only. The Reporting Persons believe that the Issuer is an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their respective positions in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisa…
Read the filing ↗
Oct 16, 2026 13D LHAI Linkhome Holdings Inc. 20.1% of LHAI's shares new stake, above 5%
Qin Zhen and 2 more reporting persons · 3.82M shares · event Sep 24, 2026
Item 4, purpose of the transaction: The Foundation received the 3,820,000 shares of common stock of the issuer as a charitable contribution from Qin Zhen to provide assets to support the Foundation's purposes. The Reporting Persons have agreed to act together with respect to the holding, voting, or disposition of such shares, as described in Item 6. The Foundation may from time to time dispose of some or all of such shares, depending upon market conditions, the Foundation's liquidity needs and charitable objectives, applicable legal and regulatory requirements and other factors the Foundation considers relevant. The Foundation has not determined the timing, amount or method of any such disposition. Any disposition may be effe…
Read the filing ↗
Oct 16, 2026 13D AIOK AI OKTO Corp. 74.2% of AIOK's shares new stake, above 5%
Pani Corp. and 1 more reporting person · 3.21M shares · event Oct 8, 2026
Item 4, purpose of the transaction: Pani received the Shares described in this Schedule 13D in connection with the Spin-Off Transaction. Any Reporting Person may from time to time acquire additional securities of the Issuer, or retain or sell all or a portion of the Shares then held by the Reporting Persons, in the open market, block trades, underwritten public offerings or privately negotiated transactions. Mr. Panagiotidis serves as the Chairman and Chief Executive Officer of the Issuer and therefore regularly engages in discussions with management of the Issuer, the board of directors of the Issuer, other shareholders of the Issuer and other relevant parties, which discussions may include matters ranging from the operation…
Read the filing ↗
Oct 16, 2026 13D TRex Bio, Inc. 19.9% of the shares new stake, above 5%
ELI LILLY & Co · 5.48M shares · event Oct 13, 2026
Item 4, purpose of the transaction: The Reporting Person acquired the securities reported herein for investment purposes and intends to continue to review its investments in the Issuer on an ongoing basis. Except as set forth herein, the Reporting Person does not currently have any specific plan or proposal to acquire or dispose of Common Stock of the Issuer or any securities exercisable for or convertible into Common Stock of the Issuer, but the Reporting Person, consistent with its investment purpose, may at any time and from time to time directly or indirectly acquire additional or all shares of Common Stock, securities exercisable for or convertible into Common Stock of the Issuer, or other securities of the Issuer, or dis…
Read the filing ↗
Oct 15, 2026 13D TCRT Alaunos Therapeutics, Inc. 20.0% of TCRT's shares new stake, above 5%
Fairmount Funds Management LLC and 4 more reporting persons · 859K shares · event Oct 13, 2026
Item 4, purpose of the transaction: The Reporting Persons own 19.99% of the Company in the aggregate, based upon the Company's aggregate outstanding shares as of September 30, 2026, plus the shares of Common Stock issued in the Financing (as defined below). The Reporting Persons' securities include (i) 687,789 shares of Common Stock and (ii) 171,000 shares of Common Stock issuable upon conversion of 171 shares of Series C Preferred Stock held directly by Co-Invest and exclude (i) 105,286,000 shares of Common Stock issuable upon conversion of 105,286 shares of Series B Preferred Stock held directly by Fund II, (ii) 52,239,000 shares of Common Stock issuable upon conversion of 52,239 shares of the Series C Preferred Stock held d…
Read the filing ↗
Oct 15, 2026 13D MXCT Maxcyte, Inc. 5.0% of MXCT's shares new stake, above 5%
Liontrust Investment Partners LLP · 5.19M shares · event Oct 14, 2026
Item 4, purpose of the transaction: (a) The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer
Read the filing ↗